We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Enforce Premarket Reviews for COVID-19 Diagnostics, Ending Pandemic Exception
FDA to Enforce Premarket Reviews for COVID-19 Diagnostics, Ending Pandemic Exception
HHS withdrew a temporary policy yesterday that directed the FDA not to enforce its premarket review requirements for laboratory developed COVID-19 tests — an emergency policy that was put in place to get tests quickly into use during the pandemic.